New coronaviral infection. Today’s look at the pandemic of the XXI century

Abstract

In this review current knowledge of disease etiology, pathogenesis, epidemiology, clinical and laboratory diagnostics, therapy and prevention, which were collected from publications of Russian specialists and researchers from different countries were summarized. Recommendations contained in the document are largely based on factual information published by experts from the World Health Organization, the Chinese and U.S. Centers for Disease Control, the European Centre for Disease Prevention and Control, and on materials from temporary methodological recommendations of the Ministry of Health of the Russian Federation and Federal Service on Surveillance for Consumer rights protection and human well-being data.

Keywords:coronavirus infection, COVID-19, SARS-CoV-2 coronavirus, pandemic, infectious morbidity

Funding. The study had no sponsor support.

Conflict of interests. The author declare no conflict of interests.

Acknowledgments. The author thanks experts for discussion, support and their willingness to share invaluable experience: Valishin D.A., Doctor of Medical Sciences, Professor, Head of the Department of Infectious Diseases with the Course of Additional Professional Education, Bashkir State Medical University of the Ministry of Healthcare of the Russian Federation, Chief External Expert for Infectious Diseases of the Ministry of Health of the Republic of Buryatia; Alekseeva E.I., Doctor of Medical Sciences, Professor, Corresponding Member of the Russian Academy of Sciences, Head of the Rheumatology Department of the National Medical Research Center for Children's Health of the Ministry of Health of the Russian Federation, Director of the Clinical Institute of children's health of the I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University), Chief External Expert for pediatric rheumatology of the Ministry of Healthcare of Russian Federation.

For citation: Malinnikova E.Yu. New coronaviral infection. Today's look at the pandemic of the XXI century. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2020; 9 (2): 18-32. DOI: 10.33029/2305-3496-2020-9-2-18-32 (in Russian)

References

1. Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol. 2020; 18 (3): 123.

2. Wang W., Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020; 92 (4): 441-7.

3. URL: https://www.ncbi.nlm.nih.gov/pubmed

4. URL: http://viro-logical.org/t7novel-2019-coronavirus-genome/319; Wuhan-Hu-1,GenBank accessionNo.MN908947.

5. WHO Coronavirus disease (COVID-19) outbreak. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

6. Ramaiah A., Arumugaswami V. Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development. bioRxiv. 2020 Jan 1.

7. Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronavi-ruses. Nat Rev Microbiol. 2019; 17 (3): 181-92.

8. Woo P.C.Y., Lau S.K.P., Lam C.S.F., et al. Discovery of seven novel mammalian and avian coronaviruses in the genus delta-coronavirus supports bat coronaviruses as the gene source of alpha-coronavirus and beta-coronavirus and avian coronaviruses as the gene source of gamma-corona-virus and delta-coronavirus. J Virol. 2012; 86 (7): 3995-4008.

9. Lee N., Hui D., Wu A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348 (20): 1986-94.

10. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013; 13 (9): 752-61.

11. Mousavizadeha L., Ghasemibc S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2020 Apr 9. URL: https://doi.org/10.1016/jjmii.2020.03.022.

12. URL: https://biomolecula.ru/articles/kompiuternye-tekhnologii-protiv-koronavirusa-pervye-rezultaty#source-25.

13. Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020; 94 (7). DOI: 10.1128/JVI.00127-20.

14. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020; 92: 418-23.

15. Xu X., Chen P., Wang J. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Life Sci. 2020; 63 (3): 457-60.

16. Jaimes J.A., Millet J.K., Stout A.E., Andre N.M., Whittaker G.R. A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses. 2020; 12 (1). pii: E83. DOI: 10.3390/v12010083.

17. URL: https://sciencepop.ru/koronavirus-mutiroval-i-stal-opasnee.

18. Lu R., Zhao X., Li J., Niu P., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395 (10 224): 565-74.

19. Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-80.

20. Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 2020; 7 (1): 1-10.

21. Wrapp D., Wang N., Corbett K. S., et al. Cryo-EM structure of the 2019-nCoV Spike in the prefusion conformation. Science. 2020; 367 (6483): 1260-3.

22. Sevajol M., Subissi L., Decroly E., et al. Review Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Res. 2014; 194: 90-9.

23. Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20 (4): 425-34.

24. Yi Y., Lagniton P.N.P., Ye S., Li E., Xu R.H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020; 16 (10): 1753-66.

25. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in

Wuhan, China. Lancet. 2020; 395 (10 223): 497-506.

26. CHANGDE-NHC: Epidemic Bulletin. URL: http://wjw.changde.gov.cn/zhdt/wjdt/content_720891.

27. Shyrobokov V.P. Medical microbiology, virology and immunology. Vinnytsia: Nova Knyga, 2015: 504-5. (in Russian)

28. URL: https://www.cdc.gov/media/releases/2020/p0130.

29. Jin X., Lian J.-S., Hu J.-H. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69 (6): 1002-9.

30. Ren S.Y., Wang W.B., Hao Y.G., Zhang H.R., Wang Z.C., et al. Stability and infectivity of coronaviruses in inanimate environments. World J Clin Cases. 2020; 8 (8): 1391-9.

31. Coronavirus disease (COVID-19) advice for the public. WHO recommendations. URL: www.who.int. (date of access February 5, 2020) (in Russian)

32. Chen J. Pathogenicity and transmissibility of 2019-nCoV - a quick overview and comparison with other emerging viruses. Microbes Infect. 2020; 22 (2): 69-71.

33. Conti P., Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul. 2020; 34 (2). DOI: 10.23812 / Editorial-Conti-3.

34. URL: https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA

35. Saghazadeh A., Rezaei N. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020; Apr 6: 1-6.

36. Coronavirus statistics today, dynamics and case map of COVID-19 (SARS-COV-2) [Electronic resource]. URL: https://koronavirus-ncov.ru/ (date of access May 8, 2020) (in Russian)

37. Decree of the Government of the Russian Federation of January 31, 2020 No. 66 «On making changes to the list of diseases that pose a danger to others». (in Russian)

38. URL: https://bit.ly/2Rftgo7-EM:RAP. (дата обращения: 31.03.2020)

39. Zhu N., Zhang D., Wang W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-33.

40. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323: 1061.

41. Gu J., Han B., Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020; 158 (6): 79-89.

47. Boettler T., Newsome P.N., Mondelli M.U., Maticic M., Cordero E., Cornberg M., et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020; 2 (3): 100113. DOI: 10.1016/j.jhepr. 2020.100113.

48. URL: https://www.lsgeotar.ru/totsilizumab.html.

49. Etzioni A., Ochs H.D. Primary Immunodeficiency Disorders: A Historic and Scientific Perspective. Amsterdam; Boston; Heidelberg : Elsevier Science; Academic Press, 2014.

50. Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Review. Nat Rev Microbiol. 2009; 7 (3): 226-36.

51. MU 3.4.2552-09 «Organization and holding of primary antiepidemic measures in cases of identifying a patient (corpse) suspected of having infectious diseases causing emergency situations in the field of public sanitary and epidemiological well-being». (in Russian)

52. Stefanyuk O.V., Lazebnik L.B. Lesions of the digestive organs when infected with SARS-CoV-2. Exp Clin Gastroenterol. 2020; 175 (3): 4-9.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»